menu
    • menu
    [{"orgOrder":0,"company":"Ostia Sciences","sponsor":"Natural Products Canada","pharmaFlowCategory":"D","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Probiotic","year":"2025","type":"Financing","leadProduct":"SALI-10","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase I","graph3":"Ostia Sciences","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"Ostia Sciences \/ Natural Products Canada","highestDevelopmentStatusID":"6","companyTruncated":"Ostia Sciences \/ Natural Products Canada"}]

    Find Clinical Drug Pipeline Developments & Deals by Ostia Sciences

    Menu

    Ostia Sciences

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ostia Sciences

                            Canada arrow
                            CPhI India
                            Not Confirmed

                            Ostia Sciences

                            Canada arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : SALI-10

                            Therapeutic Area : Dental and Oral Health

                            Study Phase : Phase I

                            Sponsor : Natural Products Canada

                            Deal Size : $1.0 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Ostia Sciences Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform

                            Details : The funding supports the advancement of their phosphorylated lantibiotic-producing probiotic technology, particularly their lead candidate SALI-10, toward clinical trials for oral health.

                            Product Name : SALI-10

                            Product Type : Probiotic

                            Upfront Cash : Undisclosed

                            July 18, 2025

                            Lead Product(s) : SALI-10

                            Therapeutic Area : Dental and Oral Health

                            Highest Development Status : Phase I

                            Sponsor : Natural Products Canada

                            Deal Size : $1.0 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth